To determine the changes of VAP-1 in patients with thyroid cancer, the serum levels of VAP-1 were measured in healthy controls, patients with benign thyroid nodules, and patients with thyroid cancer. This evidence concerns the gene AOC3 and thyroid gland carcinoma.